相关实验视频

Updated: Jul 10, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

轻度认知障碍中的神经精神障碍:科学度分析

Arisara Amrapala¹, Michel Sabé², Marco Solmi³

¹Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Cognitive Fitness and Biopsychiatry Technology Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Center of Excellence in Digital and AI for Mental Health, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand.

Ageing research reviews

|November 19, 2023

概括

这项科学度研究分析了12369篇关于轻度认知障碍 (MCI) 的行为和心理症状的出版物. 它绘制了研究趋势,确定了关键领域和新兴主题,如肠道微生物群和电子健康.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
图书统计学图书统计学

背景情况:

痴呆症的行为和心理症状 (BPSD) 在痴呆症中得到了很好的研究,但在其前兆阶段,轻度认知障碍 (MCI) 方面却不那么多.
需要科学度分析来综合MCI中BPSD的研究,揭示趋势,网络和关键贡献者.

研究的目的:

在MCI中绘制BPSD的研究演变和主导主题.
识别研究网络的特点,包括作者,期刊,国家和机构.

主要方法:

在Web of Science数据库中进行了全面的文献搜索.
从 12,369 个出版物 (1980-2022) 中提取了全文和引用记录.
分析了共同引用的参考网络,以确定研究集群和领域.

主要成果:

确定了51个具有高可信度的不同研究集群 (模块化Q=0.856,轮S=0.932).
五个主要的研究领域出现了:症状,诊断,大脑基质,生化途径和干预.
最近的研究趋势包括肠道微生物群,电子健康,COVID-19,认知和妄想.

结论:

这种科学测量分析提供了MCI中BPSD研究的全面概述.
研究结果澄清了该领域未来研究和临床实践的范围和方向.

关键词:

在CiteSpace中使用CiteSpace.证据综合研究轻度认知障碍轻度认知障碍神经精神病症状神经精神病症状科学测量公司的科学测量.

更多相关视频

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Published on: April 21, 2023

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...